Founded in Granbury, Texas, Revolver Brewing has built its reputation on pushing boundaries while staying true to its roots.

Not unlike Regeneron’s acquisition of 23andMe, Predictive Oncology’s AI-driven breakthroughs reflect a broader transformation in life sciences. The integration of genomics, machine learning, and ...

Maisha Maliha Promi, étudiante au doctorat en neurosciences, qui utilise une approche de la géroscience – c’est-à-dire l’étude de la contribution du vieillissement au développement de maladies – dans ...

CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, ...

Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1 MANCHESTER, N.H., ...

BetterLife announced on July 16, 2024, that it had amended its past Management Information Circulars (“MIC”) to correct disclosures of beneficial ownership by its Chief Executive Officer, Dr. Ahmad ...

Corporate overview Presentation Date: Thursday, June 5, 2025 Presentation Time: 11:05 a.m. ET Webcast: Click Here About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to ...

The notice from Nasdaq indicates that the Company is in compliance with the Nasdaq Capital Market's listing requirements and the Company's common stock will continue to be listed and traded on Nasdaq.

(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy ® (semaglutide), which includes ...

A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com, and will be available for 30 days.

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune characteristics of each individual patient. It engages the patient's immune system ...

The Joint Corp. extends its sincere gratitude to Glenn Krevlin for his six years of dedicated service to the board. Glenn did not stand for re-election, and Christopher M. Grandpre has filled the ...